Skip to main content
. 2016 Oct 10;5(11):3246–3259. doi: 10.1002/cam4.934

Table 1.

CXCL9 as a tumor suppressor

Type of cancer CXCL9 Expression Source Sample Number Prognosisa Ref
NSCLC Low Tumor cells 109 No relation 38
High Tumor cells 12 Might be good 37
High Tumor cells 90 Good 36
Breast cancer High Tumor cells 60 Good 42
High Tumor cells 1058 Good 43
CTCL High (early), low (advanced) Tumor cells 9 (early), 13 (advanced) Might be good 49
High Tumor cells 11 Might be good 48
Colorectal cancer Low Tumor cells 196 Poor 55
High Tumor cells 130 Good 54
UC‐Ca High Serum 10 Might be good 56
Melanoma High Tumor cells 113 Might be good 60
High Tumor cells 44 Might be good 61
Ovarian cancer High TCs, macrophages 85 Might be good 66
GC(lymphocyte‐rich) High stromal cells, a few TCs 42 Might be good 68
GC High mononuclear cells 22 Might be good 69
Ewing sarcoma High tumor and stromal cells 20 No relation 70
Cutaneous tumor High Tumor cells 42 Might be good 71

NSCLC, Non‐small‐cell lung cancer; CTCL, Cutaneous T‐cell lymphoma; UC‐Ca, ulcerative colitis‐associated cancer; RCC, Renal cell carcinoma; TCs, Tumor cells; GC, Gastric carcinoma.

a

The response as “Good” means good prognosis of cancer patients, good response to tumor therapy, or reduction of tumor burden.